HIV/Family planning and key populations

Resource
October 18, 2017

PEPFAR-funded programs for vulnerable children and adolescents are assessed using the Site Improvement Monitoring System (SIMS) to ensure that programs are meeting minimum standards and providing quality services to vulnerable children and families.

Resource
October 18, 2017

Depression, one of the most common psychiatric disorders, is two- to three-times more prevalent in people living with HIV (PLHIV) than in the general population in many settings as shown in western countries but remains neglected in sub-Saharan Africa (SSA).

Resource
October 16, 2017

Social protection can reduce HIV-risk behavior in general adolescent populations, but evidence among HIV-positive adolescents is limited.

Resource
October 12, 2017

Innovative approaches are needed to increase engagement in HIV treatment and prevention services, particularly in HIV hot spots.

Resource
October 11, 2017

The Road Map was prepared through a consultative process that brought together more than 40 countries and organizations, including civil society organizations, networks of people living with HIV, faith-based organizations, networks of key populations and international organizations and foundation

Resource
October 4, 2017

This report compiles the latest body of evidence on how stigma and discrimination create barriers across the HIV prevention, testing and treatment cascades and reduce the impact of the AIDS response.

Resource
October 4, 2017

Adolescents living with HIV are an underserved population, with poor retention in HIV health care services and high mortality, who are in need of targeted effective interventions.

Resource
October 4, 2017

The life expectancy of HIV-positive individuals receiving antiretroviral therapy (ART) is approaching that of HIV-negative people. However, little is known about how these populations compare in terms of health-related quality of life (HRQoL).

Resource
September 27, 2017

Approximately 1.4 million women living with HIV become pregnant every year. Most women use antiretroviral therapy, to reduce the risk of vertical transmission or for personal health reasons.